Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress

Neuropsychopharmacology

Volumn 37, Issue 2, 2012, Pages 456-466

  Ganon Elazar, Eti ^a   Akirav, Irit ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

basolateral amygdala; CB1 receptors; hypothalamic pituitary adrenal (HPA) axis; inhibitory avoidance extinction; post traumatic stress disorder; single prolonged stress

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; DIMETHYL SULFOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUDITORY STIMULATION; AVOIDANCE BEHAVIOR; BASOLATERAL AMYGDALA; BEHAVIOR DISORDER; COMPARATIVE STUDY; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LATENT PERIOD; LOCOMOTION; MALE; MICROINJECTION; NEGATIVE FEEDBACK; NEUROENDOCRINE DISEASE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RAT; REINFORCEMENT; STARTLE REFLEX; TASK PERFORMANCE;

AMYGDALA; ANIMALS; ANXIETY; AVOIDANCE LEARNING; BENZOXAZINES; CANNABINOIDS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAPERITONEAL; MALE; MICROINJECTIONS; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; SENSORY GATING; STARTLE REACTION; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PHYSIOLOGICAL;

EID: 84856024507     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.204     Document Type: Article

References (38)

1. Abush H, Akirav I (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20: 1126-1138.
2. Akirav I (2011). The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci 5: 34.
3. Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL et al. (2009). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci USA 106: 4888-4893.
4. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M (1993). Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 50: 294-305.
5. Chhatwal JP, Myers KM, Ressler KJ, Davis M (2005). Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci 25: 502-506. (Pubitemid 40105622)
6. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y et al. (2007). Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 148: 1574-1581. (Pubitemid 46457104)
7. Fraser GA (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in Posttraumatic Stress Disorder (PTSD). CNS Neurosci Ther 15: 84-88.
8. Ganon-Elazar E, Akirav I (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 29: 11078-11088.
9. Gorzalka BB, Hill MN, Hillard CJ (2008). Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev 32: 1152-1160.
10. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al. (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936.
11. Hill MN, Ho WSV, Meier SE, Gorzalka BB, Hillard CJ (2005). Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. Eur J Pharmacol 528: 99-102. (Pubitemid 41773658)
12. Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ et al. (2009). Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34: 2733-2745.
13. Kamprath K, Romo-Parra H, Häring M, Gaburro S, Doengi M, Lutz B et al (2011). Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 36: 652-663.
14. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A et al. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81. (Pubitemid 36098263)
15. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N et al. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21: 9506-9518. (Pubitemid 33096895)
16. Khan S, Liberzon I (2004). Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacology (Berl) 172: 225-229. (Pubitemid 38388773)
17. Kohda K, Harada K, Kato K, Hoshino A, Motohashi J, Yamaji T et al. (2007). Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience 148: 22-33. (Pubitemid 47211627)
18. Laviolette S, Grace A (2006). The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci 63: 1597-1613. (Pubitemid 44252174)
19. Liberzon I, Krstov M, Young EA (1997). Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 22: 443-453. (Pubitemid 27431506)
20. Lutz B (2009). Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9: 46-52.
21. Maroun M, Akirav I (2008). Arousal and stress effects on consolidation and reconsolidation of recognition memory. Neuropsychopharmacology 33: 394-405. (Pubitemid 350243343)
22. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534. (Pubitemid 34851398)
23. Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM (1999). Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res 822: 237-242. (Pubitemid 29222848)
24. Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK (2008). Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res 42: 515-520.
25. Orr SP, Metzger LJ, Lasko NB, Macklin ML, Peri T, Pitman RK (2000). De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. J Abnorm Psychol 109: 290-298. (Pubitemid 30616926)
26. Orr SP, Solomon Z, Peri T, Pitman RK, Shalev AY (1997). Physiologic responses to loud tones in Israeli veterans of the 1973 Yom Kippur War. Biol Psychiatry 41: 319-326. (Pubitemid 27095257)
27. Patel S, Cravatt BF, Hillard CJ (2005). Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology 30: 497-507. (Pubitemid 40271152)
28. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004). Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145: 5431-5438. (Pubitemid 39564580)
29. Patel S, Roelke CT, Rademacher DJ, Hillard CJ (2005a). Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci 21: 1057-1069. (Pubitemid 40461057)
30. Porter AC, Felder CC (2001). The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90: 45-60. (Pubitemid 32622840)
31. Rademacher DJ, Meier SE, Shi L, Vanessa Ho WS, Jarrahian A, Hillard CJ (2008). Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54: 108-116. (Pubitemid 350299407)
32. Segev A, Akirav I (2011). Differential effects of cannabinoid receptor agonist on social discrimination and contextual fear in amygdala and hippocampus. Learn Mem 29: 254-259.
33. Shalev AY, Orr SP, Peri T, Schreiber S, Pitman RK (1992). Physiologic responses to loud tones in Israeli patients with posttraumatic stress disorder. Arch Gen Psychiatry 49: 870-875.
34. Tsou K, Brown S, ograve;udo-Peòa M, Mackie K, Walker J (1997). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
35. Varvel SA, Wise LE, Niyuhire F, Cravatt BF, Lichtman AH (2007). Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 32: 1032-1041. (Pubitemid 46631982)
36. Viveros M, Marco EM, File SE (2005). Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 81: 331-342. (Pubitemid 40807131)
37. Yamamoto S, Morinobu S, Fuchikami M, Kurata A, Kozuru T, Yamawaki S (2007). Effects of single prolonged stress and Dcycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 33: 2108-2116. (Pubitemid 351992081)
38. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW (1993). Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 150: 83-86. (Pubitemid 23059168)